Evidence map›Paper›PMID 41104246›Full record

ArticleIranian journal of pharmaceutical research : IJPR

Exploring the Bioactive Compounds of

Fateme Mirzajani, Narges Parniaei, Faeze Mirzajani, Arefe Ghaderi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Iranian journal of pharmaceutical research : IJPR. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Fateme MirzajaniFaculty of Life Sciences and Biotechnology, Shahid Beheshti University, Tehran, Iran.ORCID https://orcid.org/0000-0002-6797-4243
Narges ParniaeiProtein Research Center, Shahid Beheshti University, Tehran, Iran.
Faeze MirzajaniDepartment of Agriculture and Food Science, Science and Research Branch, Islamic Azad University, Tehran, Iran.
Arefe GhaderiFaculty of Life Sciences and Biotechnology, Shahid Beheshti University, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Diabetes is a contemporary ailment characterized mainly by elevated blood glucose levels. Diabetic foot ulcers (DFUs) significantly impact the patient's quality of life and pose challenges for the healthcare system. Microalgae have emerged as effective agents for controlling inflammation owing to their elevated levels of active chemicals. Objectives: In the present study, we isolated and identified the Methods: The ethanolic extract of this algae was investigated on antibiotic-resistant Results: The results showed that compared to other extracts, the ethanolic extract effectively inhibits bacterial growth up to 70% and 30%, respectively, of levofloxacin and ceftazidime antibiotics. The study of this extract with liquid chromatography-mass spectrometry led to the identification of the astaxanthin compound as the main component of the extract. Conclusions: This study has substantial prospects for future therapeutic uses and instills hope for enhanced therapies for DFUs.

Indexed as

Bacterial InhibitionDiabetic Foot UlcerHaematococcus pluvialisStaphylococcus aureusWound Healing

Identifiers

PMID41104246
PMCPMC12523687

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.